Strong sales progress being made as distribution channel reorders continue
FREDERICK, Md., Oct. 21 /PRNewswire/ -- BioElectronics Corp. (BIEL), the maker of ActiPatch(R) Therapy, the drug free anti-inflammatory patch, with an embedded battery operated microchip delivering continuous pulse therapy that revolutionizes the way people heal; today announced it has achieved additional distribution penetration into the Canadian market. ActiPatch Therapy is now being carried by leading drug and pharmacy chains in Canada and strong reorders are taking place. These Canadian reorders and other growing international distribution is expected to allow BioElectronics to continue to meaningfully increase its revenue base.
Retail presentation of ActiPatch products in the Canadian market is through new counter top and free standing floor display units some of which hold the newly designed ActiPatch product brochure that outlines effective use of the product for the treatment of back and other chronic musculoskeletal conditions. Over the past few months the company has also made strong progress with the two largest pharmacy wholesalers within the Canadian market. These wholesalers are now making ActiPatch Therapy available to all of the smaller pharmacies throughout the country.
"We are very excited about our growing distribution and retail sales
follow through within the Canadian market commented Andrew Whelan, CEO and
President of BioElectronics Corp. "We now receiving reorders from the
distribution channel, which demonstrates that demand for ActiPatch products
within the Canadian market continues to grow. The growth in our Canadian
revenue stream, when combined with the strong results we are seeing in
other international markets, will allow the company to report record
revenues over the coming quarters. It
|SOURCE BioElectronics Corporation|
Copyright©2008 PR Newswire.
All rights reserved